Sami Corwin
Stock Analyst at William Blair
(4.68)
# 820
Out of 5,078 analysts
440
Total ratings
50.5%
Success rate
14.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sami Corwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALEC Alector | Rated: Hold | n/a | $1.83 | - | 1 | Sep 23, 2026 | |
| LEGN Legend Biotech | Rated: Hold | n/a | $19.27 | - | 19 | Sep 23, 2026 | |
| NKTX Nkarta | Rated: Hold | n/a | $1.79 | - | 16 | Sep 23, 2026 | |
| RCKT Rocket Pharmaceuticals | Rated: Hold | n/a | $2.29 | - | 24 | Sep 23, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Hold | n/a | $15.65 | - | 15 | Sep 18, 2026 | |
| OBX Obsidian Therapeutics | Initiated Coverage: Buy | $43 | $13.98 | +207.58% | 1 | Sep 9, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | n/a | $20.45 | - | 12 | Sep 9, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | n/a | $24.05 | - | 31 | Sep 8, 2026 | |
| QURE uniQure | Initiated Coverage: Buy | $73 | $22.43 | +225.46% | 30 | Sep 2, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Hold | n/a | $55.95 | - | 15 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $49.39 | - | 21 | Aug 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.25 | - | 29 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.47 | - | 28 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.39 | - | 13 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $23.55 | - | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.92 | - | 20 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.389 | - | 16 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.81 | - | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $311.50 | - | 20 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $15.73 | +19.20% | 1 | May 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $17.73 | - | 20 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $60.59 | - | 41 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.46 | n/a | 15 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.28 | n/a | 5 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.96 | n/a | 4 | Feb 1, 2023 |
Alector
Sep 23, 2026
Rated: Hold
Price Target: n/a
Current: $1.83
Upside: -
Legend Biotech
Sep 23, 2026
Rated: Hold
Price Target: n/a
Current: $19.27
Upside: -
Nkarta
Sep 23, 2026
Rated: Hold
Price Target: n/a
Current: $1.79
Upside: -
Rocket Pharmaceuticals
Sep 23, 2026
Rated: Hold
Price Target: n/a
Current: $2.29
Upside: -
Ultragenyx Pharmaceutical
Sep 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $15.65
Upside: -
Obsidian Therapeutics
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $13.98
Upside: +207.58%
Tyra Biosciences
Sep 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $20.45
Upside: -
Beam Therapeutics
Sep 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $24.05
Upside: -
uniQure
Sep 2, 2026
Initiated Coverage: Buy
Price Target: $73
Current: $22.43
Upside: +225.46%
BioMarin Pharmaceutical
Aug 31, 2026
Reiterated: Hold
Price Target: n/a
Current: $55.95
Upside: -
Aug 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $49.39
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.25
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.47
Upside: -
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.39
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $23.55
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.92
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.389
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.81
Upside: -
Aug 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $311.50
Upside: -
May 2, 2026
Initiated Coverage: Buy
Price Target: $19
Current: $15.73
Upside: +19.20%
Feb 26, 2026
Reiterated: Hold
Price Target: n/a
Current: $17.73
Upside: -
Feb 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $60.59
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $1.46
Upside: n/a
Dec 22, 2023
Rated: Hold
Price Target: n/a
Current: $12.28
Upside: n/a
Feb 1, 2023
Reiterated: Buy
Price Target: n/a
Current: $3.96
Upside: n/a